Curcumin: A novel Stat3 pathway inhibitor for chemoprevention of lung cancer

European Journal of Cancer Prevention

Volumn 21, Issue 5, 2012, Pages 407-412

  Alexandrow, Mark G ^a   Song, Lanxi J ^a   Altiok, Soner ^a   Gray, Jhanelle ^a   Haura, Eric B ^a   Kumar, Nagi B ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

chemoprevention; curcumin; former smokers; signal transducer and activator of transcription 3 inhibitors

Indexed keywords

CURCUMIN; CYCLIN D1; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; MINICHROMOSOME MAINTENANCE PROTEIN 2; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM CELL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; MOUSE; NONHUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SMOKING;

ANIMALS; CELL LINE; CURCUMIN; ENZYME INHIBITORS; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; RANDOM ALLOCATION; STAT3 TRANSCRIPTION FACTOR;

EID: 84864357972     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834ef194     Document Type: Article

References (53)

1. Aggarwal BB, Harikumar KB (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular. Cell Biol 41:40-59.
2. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, et al. (2006). Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091:151-169. (Pubitemid 47092233)
3. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008). Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 267:133-164.
4. Banerjee S, Manna S, Saha P, Panda CK, Das S (2005). Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev 14:215-221. (Pubitemid 40780444)
5. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC (2011). Advanced drug-delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res (Phila) 4:1158-1171.
6. Bell SP, Dutta A (2002). DNA replication in eukaryotic cells. Annu Rev Biochem 71:333-374. (Pubitemid 34800224)
7. Bianchini F, Vainio H (2003). Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev 12:417-425. (Pubitemid 37338816)
8. Bill MA, Fuchs JR, Li C, Yui J, Bakan C, Benson DM Jr, et al. (2010). The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer 9: 165.
9. Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, et al. (2011). Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 4:354-364.
10. Chen Q, Wang Y, Xu K, Lu G, Ying Z, Wu L, et al. (2010a). Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Oncol Rep 23: 397-403.
11. Chen QY, Lu GH, Wu YQ, Zheng Y, Xu K, Wu LJ, et al. (2010b). Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep 23: 1285-1292.
12. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21 (4B):2895-2900.
13. Cho JW, Lee KS, Kim CW (2007). Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19:469-474.
14. Choudhuri T, Pal S, Das T, Sa G (2005). Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280:20059-20068. (Pubitemid 41379535)
15. Cortas T, Eisenberg R, Fu P, Kern J, Patrick L, Dowlati A (2007). Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer. Lung Cancer 55:349-355. (Pubitemid 46343578)
16. Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, et al. (2007). Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 117:3846-3856. (Pubitemid 350224094)
17. Garfinkel L, Silverberg E (1991). Lung cancer and smoking trends in the United States over the past 25 years. CA Cancer J Clin 41:137-145.
18. Goel A, Kunnumakkara AB, Aggarwal BB (2008). Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75:787-809 Review.
19. Halappanavar S, Russell M, Stampfli MR, Williams A, Yauk CL (2009). Induction of the interleukin 6/signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke. BMC Med Genomics 2:56.
20. Haura EB, Turkson J, Jove R (2005a). Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2:315-324. (Pubitemid 40903176)
21. Haura EB, Zheng Z, Song L, Cantor A, Bepler G (2005b). Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Clin Cancer Res 11:8288-8294. (Pubitemid 41746939)
22. Haura EB, Livingston S, Coppola D (2006). Autocrine interleukin-6/ interleukin-6 receptor stimulation in non-small-cell lung cancer. Clin Lung Cancer 7:273-275. (Pubitemid 43280031)
23. Irvin JE, Brandon TH (2000). The increasing recalcitrance of smokers in clinical trials. Nicotine Tob Res 2:79-84.
24. Janakiram NB, Mohammed A, Zhang Y, Choi CI, Woodward C, Collin P, et al. (2010). Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth. Cancer Prev Res (Phila) 3:82-91.
25. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). Cancer statistics, 2007. CA Cancer J Clin 57:43-66. (Pubitemid 46148091)
26. Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, et al. (2011). Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev Res (Phila) 4:793-802.
27. Kelly K, Kittelson J, Franklin WA, Kennedy TC, Klein CE, Keith RL, et al. (2009). A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer. Cancer Prev Res (Phila) 2:440-449.
28. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y (1993). Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull (Tokyo) 41:1640-1643. (Pubitemid 23326798)
29. Kunnumakkara AB, Anand P, Aggarwal BB (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199-225.
30. Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10.
31. Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, et al. (2010). Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res 173: 590-601.
32. Li Y, Du H, Qin Y, Roberts J, Cummings OW, Yan C (2007). Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res 67:8494-8503. (Pubitemid 47437423)
33. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, et al. (2009). Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and vascular endothelial growth factor (VEGF). Cancer Lett 285:127-133.
34. Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, Brooks MW, et al. (2002). Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 21:4577-4586. (Pubitemid 34785734)
35. Lynch TJ, Adjei AA, Bunn PA Jr, Eisen TG, Engelman J, Goss GD, et al. (2006). Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents. Clin Cancer Res 12:4365s-4371s. (Pubitemid 44197183)
36. Moghaddam SJ, Barta P, Mirabolfathinejad SG, Ammar-Aouchiche Z, Garza NT, Vo TT, et al. (2009). Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 30:1949-1956.
37. Mukherjee P, Cao TV, Winter SL, Alexandrow MG (2009). Mammalian MCM loading in late-G(1) coincides with Rb hyperphosphorylation and the transition to post-transcriptional control of progression into S-phase. PLoS ONE 4:e5462.
38. Mukherjee P, Winter SL, Alexandrow MG (2010). Cell cycle arrest by transforming growth factor beta1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction. Mol Cell Biol 30:845-856.
39. Nicholson AG, Perry LJ, Cury PM, Jackson P, McCormick CM, Corrin B, Wells AU (2001). Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation. Histopathology 38:202-208. (Pubitemid 32862728)
40. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, et al. (2002). Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 8:314-346.
41. Pastorino U (1994). Lung cancer chemoprevention. Eur J Cancer Prev 3: 371-373 Review.
42. Pillai S, Rizwani W, Li X, Rawal B, Nair S, Schell MJ, et al. (2011). ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol Cell Biol 31:3052-3067 Epub 2011 May 23.
43. Riboli E (1996). Nutrition and cancer of the respiratory and digestive tract: results from observational and chemoprevention studies. Eur J Cancer Prev 5 (Suppl 2):9-17. (Pubitemid 27085333)
44. Sameermahmood Z, Balasubramanyam M, Saravanan T, Rema M (2008). Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs). Invest Ophthalmol Vis Sci 49:3305-3311.
45. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847-6854. (Pubitemid 39383033)
46. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64:353-356. (Pubitemid 28234275)
47. Song L, Turkson J, Karras JG, Jove R, Haura EB (2003). Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22:4150-4165. (Pubitemid 36876236)
48. Suresh D, Srinivasan K (2010). Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res 131: 682-691.
49. Tong L, Spitz MR, Fueger JJ, Amos CA (1996). Lung carcinoma in former smokers. Cancer 78:1004-1010. (Pubitemid 26284865)
50. Wu SH, Hang LW, Yang JS, Chen HY, Lin HY, Chiang JH, et al. (2010). Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways. Anticancer Res 30:2125-2133.
51. Yeh HH, Lai WW, Chen HH, Liu HS, Su WC (2006). Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25:4300-4309. (Pubitemid 44100500)
52. Yu H, Jove R (2004). The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4:97-105. (Pubitemid 38198738)
53. Yu R, Jiao JJ, Duh JL, Gudehithlu K, Tan TH, Kong AN (1997). Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 18:451-456. (Pubitemid 28132441)